Literature DB >> 10657530

Pituitary adenylate cyclase-activating polypeptide (PACAP-27) enhances tyrosine hydroxylase activity in the nucleus accumbens of the rat.

A Moser1, J Scholz, A Gänsle.   

Abstract

Pituitary adenylate cyclase-activating polypeptide (PACAP-27) was incubated in a tyrosine hydroxylase (TyrOH) assay with a homogenate preparation of the nucleus accumbens of the rat. TyrOH activity was determined in vitro by measuring the production of L-dopa with HPLC-ECD. Only in the presence of adenosine nucleotides (ATP, App(NH)p) PACAP-27 increased TyrOH activity with a EC(50)of 100 nM. Since the PACAP-27 effect on TyrOH was abolished when homogenate or pellet of the nucleus accumbens were coincubated with CHAPS, the peptide effect appears to be receptor mediated. TyrOH activation produced by PACAP-27 increased in the presence of the phosphodiesterase inhibitor papaverine indicating the involvement of cAMP. The marked effect of the non-hydrolysable adenosine nucleotide App(NH)p also supports a cAMP-dependent TyrOH activation not related to ADP or an ADP-dependent mechanism. This report's data suggest that PACAP-27 activates TyrOH in the rat nucleus accumbens through receptor-mediated cAMP formation. The exact receptor type present in the nucleus accumbens has yet not been specified. Copyright 1999 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10657530     DOI: 10.1054/npep.1999.0768

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  6 in total

1.  Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP).

Authors:  H Hashimoto; N Shintani; K Tanaka; W Mori; M Hirose; T Matsuda; M Sakaue; J Miyazaki; H Niwa; F Tashiro; K Yamamoto; K Koga; S Tomimoto; A Kunugi; S Suetake; A Baba
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

2.  Altered social behavior in pituitary adenylate cyclase-activating polypeptide type I receptor-deficient mice.

Authors:  Arnaud Nicot; Timothy Otto; Philippe Brabet; Emanuel M Dicicco-Bloom
Journal:  J Neurosci       Date:  2004-10-06       Impact factor: 6.167

3.  PACAP deficiency sensitizes nigrostriatal dopaminergic neurons to paraquat-induced damage and modulates central and peripheral inflammatory activation in mice.

Authors:  M B Watson; H Nobuta; C Abad; S K Lee; N Bala; C Zhu; F Richter; M-F Chesselet; J A Waschek
Journal:  Neuroscience       Date:  2013-03-14       Impact factor: 3.590

4.  The role of endogenous PACAP in motor stimulation and conditioned place preference induced by morphine in mice.

Authors:  Paul Marquez; David Bebawy; Vincent Lelièvre; Anne-Claire Coûté; Christopher J Evans; James A Waschek; Kabirullah Lutfy
Journal:  Psychopharmacology (Berl)       Date:  2009-02-08       Impact factor: 4.530

5.  Alterations of Nigral Dopamine Levels in Parkinson's Disease after Environmental Enrichment and PACAP Treatment in Aging Rats.

Authors:  Adel Jungling; Dora Reglodi; Gabor Maasz; Zita Zrinyi; Janos Schmidt; Adam Rivnyak; Gabor Horvath; Zsolt Pirger; Andrea Tamas
Journal:  Life (Basel)       Date:  2021-01-08

6.  Examination of pituitary adenylate cyclase-activating polypeptide in Parkinson's disease focusing on correlations with motor symptoms.

Authors:  Daniel Pham; Beata Polgar; Tunde Toth; Adel Jungling; Norbert Kovacs; Istvan Balas; Endre Pal; Dora Szabo; Balazs Daniel Fulop; Dora Reglodi; Zalan Szanto; Robert Herczeg; Attila Gyenesei; Andrea Tamas
Journal:  Geroscience       Date:  2022-02-26       Impact factor: 7.581

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.